In Case You Missed It
5 Things You Must Know Before the Market Opens
Jim Cramer's Daily Booyah
Winners & Losers
Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.
Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.
M&A, drug approvals and Trump are all on my watch list.
Here are some names that have caught our eye.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.